We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
73 hedge funds and large institutions have $117M invested in State Street SPDR S&P Pharmaceuticals ETF in 2020 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 17 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
894% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $335K
40% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 15
18% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 17
9% more funds holding
Funds holding: 67 → 73 (+6)
7% more capital invested
Capital invested by funds: $109M → $117M (+$7.69M)
15.11% less ownership
Funds ownership: 60.76% → 45.65% (-15%)
Holders
73
Holders Change
+6
Holders Change %
+8.96%
% of All Funds
1.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
17
Closed
15
Calls
$3.33M
Puts
$335K
Net Calls
+$3M
Net Calls Change
-$369K
Top Buyers
| 1 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$3.59M |
| 2 |
CI
CX Institutional
Auburn,
Indiana
|
+$1.67M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
+$1.35M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$1.15M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.11M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$15.4M |
| 2 |
JP Morgan Chase
New York
|
-$7.32M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$1.03M |
| 4 |
BCM
Brookstone Capital Management
Wheaton,
Illinois
|
-$738K |
| 5 |
Goldman Sachs
New York
|
-$650K |
